As is being sedentary - there are probably lots of interconnected factors in play, and GLP-1 receptor agonists seem to help with more than one (perhaps even many) of them.

Unpicking the exact chains of causation is likely going to be extremely complex, but the general picture continues to look good.

We should probably be studying people who wear smart watches and collecting the activity levels to control for that.

But if GLP-1 makes you more active, who am I to complain. There's the reason they approve stomach stapling surgeries on morbidly obese people. They are so compromised that anything that gives them a chance to be more active offsets some of the risks of surgery, and the risks of inaction.

[dead]